top of page

advocatING for COVID-19 treatmentS 

OPTIMIST advocates for the early treatment of COVID-19 as well as treatments for the after effects of the spike protein contracted either through COVID or COVID vaccination. 

ministry of health & wellness protocols

The Ministry of Health & Wellness has a very limited outpatient protocol for early treatment, which is "Stay at home except to get medical care".

Screenshot 2024-01-25 at 5.40.32 PM.png

EARLY TREATMENTS FOR COVID-19

There are several documented early treatment protocols that were utilised by OPTIMIST Doctors to prevent severe disease, hospitalisation and death in patients during the pandemic.

Please refer to our disclaimer here

TREATMENTS FOR THOSE SUFFERING FROM LONG COVID OR VACCIne injurIES

There are starting to appear in the medical literature treatments for Long COVID and vaccine injuries. As the material is published, we will be adding it here.

Please refer to our disclaimer here

clinical guidance for medical practitioners

Screenshot 2024-03-07 at 6.52.33 PM.png

IVERMECTIN

There are over 100 different studies, often ignored by critics, that demonstrate Ivermectin's efficacy. Here are ten that jump out:

S. Ahmed et al. (2020): Outcome: 85% improved symptoms (p=0.09), 76% improved viral clearance (p=0.03).

Screenshot 2024-06-13 at 7.20.20 PM

R. Chahla et al. (2021): Outcome: 95% fewer moderate/severe cases (p=0.002) and 84% fewer cases (p=0.004). No moderate/severe cases in the treatment group vs. 10 in the control group.

Screenshot 2024-06-13 at 7.25.02 PM

R. Mahmud et al. (2020): Outcome: 86% lower mortality (p=0.25), 57% lower progression (p=0.001), 94% improved recovery (p<0.0001), and 39% improved viral clearance (p=0.002).

V. Desort-Henin et al. (2023): Outcome: 96% fewer cases (p<0.0001) with pre-exposure prophylaxis.

M. Varnaseri et al. (2024): Outcome: 82% lower ventilation (p=0.02), 83% lower ICU admission (p=0.0004), 33% shorter hospitalization (p=0.001), and 28% faster recovery (p<0.0001).

A. Biber et al. (2021): Outcome: 70% lower hospitalization (p=0.34) and 62% improved viral clearance (p=0.02).

R. Chahla et al. (2021): Outcome: 87% higher hospital discharge (p=0.004)

M. Khan et al. (2020): Outcome: 87% lower mortality (p=0.02), 89% lower ICU admission (p=0.007), 83% lower progression (p=0.0004), and 87% improved recovery (p=0.02).

Z. Aref et al. (2021): Outcome: 63% improved recovery (p=0.0001) and 79% improved viral clearance (p=0.004).

A. Chowdhury et al. (2020) Outcome: 81% lower hospitalization (p=0.23), 46% improved recovery (p<0.0001), and 81% improved viral clearance (p=0.23).

bottom of page